首席运营官邵炜慧减持金斯瑞生物科技(01548)约11.55万股 每股作价约17.35港元

Group 1 - The Chief Operating Officer of Genscript Biotech Corporation, Shao Weihui, reduced his holdings by 115,538 shares at a price of HKD 17.3544 per share, totaling approximately HKD 2.0051 million [1] - After the reduction, the latest number of shares held by Shao Weihui is approximately 6.8385 million, representing a holding percentage of 0.31% [1]